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The use of multi-scale mathematical and computational models to study complex
biological processes is becoming increasingly productive. Multi-scale models span
a range of spatial and/or temporal scales and can encompass multi-compartment
(e.g., multi-organ) models. Modeling advances are enabling virtual experiments
to explore and answer questions that are problematic to address in the wet-lab.
Wet-lab experimental technologies now allow scientists to observe, measure,
record, and analyze experiments focusing on different system aspects at a vari-
ety of biological scales. We need the technical ability to mirror that same ﬂex-
ibility in virtual experiments using multi-scale models. Here we present a new
approach, tuneable resolution, which can begin providing that ﬂexibility. Tune-
able resolution involves ﬁne- or coarse-graining existing multi-scale models at the
user’s discretion, allowing adjustment of the level of resolution speciﬁc to a ques-
tion, an experiment, or a scale of interest. Tuneable resolution expands options for
revising and validating mechanistic multi-scale models, can extend the longevity
of multi-scale models, and may increase computational efﬁciency. The tuneable
resolution approach can be applied to many model types, including differential
equation, agent-based, and hybrid models. We demonstrate our tuneable resolu-
tion ideas with examples relevant to infectious disease modeling, illustrating key
principles at work. © 2014 The Authors. WIREs Systems Biology and Medicine published by Wiley
Periodicals, Inc.
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INTRODUCTION
Continued advances in biomedical science willrequire more explanatory mathematical and
computational models.1–9 Increasingly these models
are multi-scale, encompassing processes operating at a
range of temporal and spatial scales and perhaps also
between multiple compartments (e.g., organs). The
key goal of multi-scale modeling in medically focused
systems biology is the generation of models that can
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be used to better understand hypothesized mecha-
nisms, make predictions, interpret data, suggest new
approaches for therapy, and offer new explanations
for observed phenomena.
Advances in multi-scale modeling are enabling
virtual experiments to answer questions that can be
problematic to address in a wet-lab.10–15 In wet-lab
experiments, advances in technology now allow sci-
entists the flexibility to observe, measure, record, and
analyze experiments at a variety of scales. We need the
same capability in our virtual experiments (Figure 1).
While virtual experiments cannot replace experimen-
tation on living systems, they can be used to create new
knowledge and improve explanatory insight. To do so,
we develop, explore, and challenge alternative, plausi-
ble mechanistic scenarios, including hypotheses within
and across scales. As progress is made, we can increase
the synergy between virtual and wet-lab experiments.
Such synergy is expected to be most productive as our
multi-scale models become increasingly analogous to
their animal model and human counterparts at multi-
ple scales, under an expanding variety of intervention
scenarios.
One strategy to achieving such flexibility and
increasing the useability of multi-scale models is
an approach we term tuneable resolution. Tune-
able resolution proposes that multi-scale models
should be built with multiple levels of resolution, so
that a fine-grained or coarse-grained version can be
employed with user discretion, allowing adjustment
of the level(s) of resolution specific to a question,
an experiment, a particular use, or a change in per-
spective or scale of interest. In addition to providing
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FIGURE 1 | Coupled use of wet-lab and virtual experiments. Left
side: Scientiﬁc ﬂow of wet-lab experiments from design through
interpretation. Right side: Scientiﬁc ﬂow of virtual experiments from
design through interpretation. Two cycles intersect to generate
hypotheses to pose and address new questions. Iteration is a key
component of this process and involves multiple cycles on either or both
sides.
this flexibility of level of resolution, we argue that
a tuneable resolution approach expands options for
revising and validating models and increases model
usability and portability.
We describe our tuneable resolution approach
starting with arguments for, and evolving principles
guiding, its use. We then demonstrate resolution tun-
ing in models of the immune response to infection with
Mycobacterium tuberculosis, the pathogen that causes
tuberculosis (TB) (Examples 1–3). Despite many dif-
ferent and insightful experimental approaches taken
over the years, fundamental questions remain about
TB. In the TB context, virtual experiments pro-
vide means and strategies for generating and testing
hypotheses about the disease, its mechanisms, and
potential treatments.16
THE ARGUMENT FOR TUNEABLE
RESOLUTION
Tuneable Resolution Provides Flexibility
Required to Span Varying Aspects
and Scales of Interest
Experiments on living systems often focus on a single
aspect (or feature) and a single scale. Multiple types of
experiments allow access to information at different
scales. For example, images of diseased lungs provide
information about the spread of TB, whereas immune
responses developing in draining lymph nodes (LNs)
determine how well infection can be controlled. We
need the flexibility and technical ability to change an
aspect of a multi-scale model on which a new virtual
experiment focuses and, when needed, the observa-
tion interval and frequency (Figure 2). We also need
to retain essential knowledge when the aspect of
interest changes, e.g., from signaling networks within
an immune cell to immune cells interacting with
each other. Models built with tuneable resolution can
achieve this.
Tuneable Resolution Enables More
Comprehensive Model Validation
We can improve both explanatory and predictive use-
fulness by improving phenotypic overlap between phe-
nomena generated by multi-scale models and their real
world counterparts. To do so we must increase the
variety of ways that results from virtual experiments
can either be validated against corresponding wet-lab
experiments or be objectively compared to available
knowledge. We improve the scientific usefulness of
multi-scale models by building trust into simulated
mechanisms using a tuneable resolution approach
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FIGURE 2 | Tuneable resolution approach. Top: An initial model (shown as 3 puzzle pieces) functions within an environment (A1). Fine-graining a
portion of the initial model to generate A2a, and subsequently a portion of that latter model to generate A3, adds additional scales of relevance.
Progression from A3 to A2b demonstrates re-engineering of the previous scale model (A2a) to reﬂect knowledge gained at A3. Bottom: An initial
model is reﬁned to include additional scales of interest in the environment as model development progresses from B1 through B3. Depending on the
question or aspect, the user choses the appropriate level of resolution.
and multiple validation targets. Trust increases in
two ways: improving in silico-to-wet-lab similari-
ties and identifying when, why, and where dissimi-
larities occur. We provide examples supporting our
case that both activities require a tuneable resolution
approach.
Fine-Graining May Present Strategies
for Re-engineering to Obtain an Improved
Coarse-grained Model
There are many computational and mathematical
considerations that emphasize caution when adding
fine-grain information to multi-scale models. A tune-
able resolution approach argues not only for gradually
and systematically building in additional detail into a
model (as warranted by available data and questions
being asked) but also for informing the formulation
of a more biologically accurate coarse-grained version
by using information from the fine-grained model.
For example, an original coarse-grained model is
developed and, because of further biological ques-
tions or additional validation targets, a finer-grained
version is created (Figure 2, A1 ->A2a ->A3; Figure 2,
B1 ->B2 ->B3). Once those questions are answered,
the user wishes to return to a simpler representa-
tion but that preserves the biological integrity of the
system (although not necessarily the mathematical
integrity): a tuneable resolution approach provides
a coarse-grained model that has been improved by
insights gained during virtual experiments on the
fine-grained model. This process helps one discover
what mechanisms must appear in the model, and
at what level of detail, to explain corresponding
biological data (Figure 2, A3 ->A2b). Put another
way, the re-engineered coarse-grained model can be
thought of as a ‘model of a model’, i.e., a version
that retains some, but not all, finer-grained model
behaviors.
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Tuneable Resolution Can Help Identify
Model Flaws
Models are perpetual works in progress. New insights,
from either virtual or wet-lab experiments, can falsify
one or more mechanistic model features, requiring
model revision. The multiple perspectives offered by
models capable of tuneable resolution may reduce
bias and enable identifying the location of a model
flaw, and thus can reduce reengineering required to
produce and validate resulting revised and improved
models.
Tuneable Resolution May Help Identify
the Scale Location of a ‘Tipping Point’
An overarching goal for biomedical research is dis-
covery of new intervention strategies that improve
health outcomes. For TB, diabetes, cardiovascular dis-
eases, and others that are still shrouded in consid-
erable uncertainty, the scale location of the tipping
point for a therapeutic intervention under study can
be unknown and may even vary between individu-
als. For example, should a therapy target a specific
receptor–ligand interaction in a specific biological
organ, the expansion of a class of T cells, or are
both required but following a coordinated strategy?
We envision that virtual experiments using tuneable
resolution provide new options for expediting and
narrowing the search. This would arise, e.g., when
creating a new coarse-grained sub-model to replace a
fine-grained sub-model (Figure 2). Key model mech-
anisms that are required to preserve the behavior
obtained with the fine-grained are likely tipping points
for the combinedmulti-scale model behavior. In a non-
linear ordinary differential equation (ODE) system,
e.g., those necessary preserved behaviors may identify
bifurcation parameters that are targets for therapeutic
interventions.
Tuneable Resolution Approaches Can
Increase Computational Speed, Model
Usefulness, and Portability
Most multi-scale models grow in complexity and
scope as researchers add mechanisms and detail
to improve agreement and usefulness in interpret-
ing experimental data. Consequently, the model can
become increasingly difficult to work with—more
difficult to debug, to port to other platforms and
other users—and the results of virtual experiments
may become more difficult to interpret. Simulations
may require significantly longer runtimes. Indeed,
some models essentially ‘die’ under their own weight,
becoming too complex to be passed on to the next
user. Tuneable resolution approaches, particularly
those emphasizing modularity, model linking, and
re-engineering of coarse-grained model versions, can
assist in avoiding or reducing these problems.
EVOLVING PRINCIPLES FOR BUILDING
TUNEABLE RESOLUTION MODELS
Resolution Tuning Requires Coupled Use
of Coarse- and Fine-Graining Methods
Our model development typically proceeds by first
including well-studied and characterized processes
known to have major or first-order effects on sys-
tem behavior. Given specific questions to be addressed
in virtual experiments, some biological processes may
not require great detail in their description, and so can
be represented in a coarse-grained fashion, e.g., using
a parameter or a simple phenomenological expres-
sion. New biological questions or data might later
require virtual experiments that have a new focus and
new multi-scale model uses, and that, in turn, may
require increased model resolution, or fine-graining,
e.g., replacing the parameter or simple phenomeno-
logical expression with a sub-model that simulates rel-
evant biological processes in greater detail. Adding
information from multiple length and time scales,
while important for simulating phenomena, signifi-
cantly increases the complexity of analyses and execu-
tion time. Thus it is important to be able to selectively
(and possibly automatically) coarse-grain model com-
ponents and/or features when needed. Coarse-graining
can be achieved by replacing a sub-model consisting
of several biologically based equations or rules with
wisely chosen phenomenological expressions (e.g., a
parameter, a function, or a simplified model). These
choices may be guided by temporal considerations
(e.g., pseudo steady-state assumption), by valida-
tion targets, and/or by information obtained during
building and execution of the fine-grained model.
Note that there is no single method for coarse- or
fine-graining, and strategies vary by field. Various
model structures will require different methods and
a review of these methods is beyond the scope of
this article.
Tuneable Resolution Can Be Used
with Different Multi-Scale Model Constructs
Multi-scale models with similar uses can have
different constructs, including ODE, partial dif-
ferential equation (PDE), stochastic, object- and
agent-based, and hybrid (i.e., models combining dif-
ferent constructs).17–26 Consequently there is no single
strategy for achieving tuneable resolution. Regardless
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of construct type, it is important to have the ability
to shift the aspect and/or scale of focus at will. In
Examples 1 and 2, we demonstrate tuneable resolution
using hybrid models that combine nonlinear systems
of ODEs as sub-models that fine-grain mechanisms
of an agent-based model (ABM). In addition, organ
compartments of interest can be represented using
either coarse- or fine-grained versions as appropriate
for the particular virtual experiment (Example 3).
Model Linking Is Central to
Tuneable Resolution
Resolution tuning and established multi-resolution
modeling methods face several similar technical,
implementation, computational, and mathematical
issues. Interfacing or linking independent model
components that operate at different temporal or
spatial granularities is a prominent example.27–29
Interfacing or linking independent model compo-
nents that use different modes of computation (e.g.,
agent-based and continuous mathematics) is another.
Adjusting the resolution in a model requires explicit
consideration of model linking issues. There are
no standard linking methods. Although details are
beyond the scope of this communication, we note
that several groups are developing frameworks to
modularize models to improve model linking with an
eye toward efficient modeling.7–9,30–38 For example,
the multi-scale modeling platforms CompuCell 3D
(www.compucell3d.org), Simmune, and Virtual
Cell (http://www.ibiblio.org/virtualcell/) all provide
approaches for model linking.39–41
Modularity Becomes Necessary,
Even Essential
Another impediment in the quest for improved
multi-scale models is that they can become so com-
plicated that scientific utility is jeopardized. The
cost to copy, verify, and maintain their operation
can be prohibitive. In addition, considerable spe-
cialized expertise and training is needed to conduct
virtual experiments using current multi-scale models.
Finally, the barrier to independent virtual experiment
replication (as distinct from repetition) becomes too
great.42–47 Our experience is that because model
variants identified during virtual experiments employ-
ing tuneable resolution are somewhat specialized,
they can be easier to share and have shorter learning
curves. There is value to moving in the direction
of multi-scale models designed intentionally to be
modular at all scales, where module variants having
the same biological counterpart but different mecha-
nistic granularities can be exchanged with biomimetic
fidelity and confidence bothwithin and between exper-
iments. As these modules become more long-lived, our
expectation is that it will become increasingly easy to
replicate virtual experiments (a standard in science),
and that barriers to more widespread use of virtual
experiments will be lowered. Research to improve
model modularity is an actively expanding activ-
ity (http://www.imagwiki.nibib.nih.gov/mediawiki/
index.php?title=Main_Page).
Uncertainty and Sensitivity Analyses Play
Important, and Multiple, Roles in
Tuneable Resolution
When data are not available to determine some model
parameter values, uncertainty and sensitivity analyses
can be used to investigate, narrow and define param-
eter spaces. Key generalized features of the process
are illustrated in Figure 3. The first role for uncer-
tainty analysis is to assess the uncertainty in model
output that results from uncertainty in parameter val-
ues. Common techniques include generalized Monte
Carlo methods (e.g., simple random sampling, Latin
hypercube sampling).48 Sensitivity analysis is then
used to quantify how parameter uncertainty impacts
model outcomes and to identify critical model param-
eters. Common techniques include generalized corre-
lation (e.g., partial rank correlation coefficients) and
variance decomposition methods (e.g., ANOVA, fast
Fourier transform).48 The second role for uncertainty
and sensitivity analyses in tuneable resolution is to
identify key mechanism features to guide fine-graining
and sub-model development. For example, we can
fine-grain a model by adding detail to processes sug-
gested by sensitivity analysis as significant or we
can coarse-grain by conflating sets of parameters
that do not have a large impact on model outcome.
Most sensitivity analysis techniques supply indices
that are time-dependent; key regulatory mechanisms
can be important only during certain—sometimes
narrow—time intervals. Such time-dependency can
also be exploited to guide when to change resolution in
an automated fashion. For example, if sensitivity anal-
ysis suggests that a certain mechanism is only impor-
tant early, then we can use the fine-grain model version
early during the virtual experiment and, based on set
criteria, switch to a coarse-grain version thereafter.49
That illustration highlights that tuneable resolution
can be applied temporally as well as spatially. Finally,
we use uncertainty and sensitivity analyses for esti-
mating new parameter values when toggling between
coarse- and fine-grained model versions (i.e., tuneable
resolution) to maintain biological fidelity and model
congruency with regard to key biological features
(Figure 3).
Volume 6, Ju ly/August 2014 © 2014 The Authors. WIREs Systems Biology and Medicine published by Wiley Periodicals, Inc. 229
Advanced Review wires.wiley.com/sysbio
Biological
system
Coarse-
grained
(a) (b) (c)
Fine-
grained
FIGURE 3 | Comparing the behavior of multi-scale models
(determined with virtual experiments) and the behavior of a biological
system (determined with wet-lab experiments). The degree to which a
model captures the biological system is represented by overlap between
the model and biological system shapes (purple and yellow, or green
and yellow). The degree to which the ﬁne- and coarse-grained models
predict the same behavior is represented by overlap between the purple
and green shapes. In order to toggle between the two models to
simulate resolution tuning, acceptable similarities (sufﬁcient
congruency) for the same set of phenomena must be observed. After
initial sensitivity and uncertainty analyses, phenomena overlap between
the sibling models is typically inadequate, indicating that further
reﬁnements are needed, possibly in both models, providing a degree of
cross-model validation (panels a–c). Because the two model versions
are not the same, we should not expect complete overlap across their
full range of realizations. Hayenga et al.106 provide an instructive
demonstration of achieving congruency between an agent-based and a
continuum-based biomechanical model.
Tuneable Resolution Is Distinguishable from
Multi-Resolution Modeling
Multi-resolution modeling refers to building a sin-
gle model, a family of models, or both to describe
the same phenomena at different levels of resolu-
tion, across multiple scales. Multi-resolution model-
ing has a rich history in other domains, most notably
conflict and combat modeling50–54 and ecology.55–58
However, two important characteristics distinguish
many of those models from the tuneable resolution
approach described here. First, multi-resolution mod-
eling efforts typically adopt a reductionist, bottom-up
approach, assuming that knowledge, measurements,
and data are available to achieve an acceptable degree
of biological validation at the finest grain (Figure 4,
right side)59,60; modeling typically begins with math-
ematical descriptions of multi-level mechanisms that
are physics-based. Yet, for TB and many other med-
ical fields, the fine grain, explanatory, mechanistic
knowledge needed to build a classical multi-resolution
model is still not available, placing us toward the
aqua area of Figure 4. In fact, a primary goal in
our research has been to use virtual experiments to
facilitate acquiring this knowledge. We have begun
with rather coarse-grained models, refining them to
generate biomimetic phenomena, and then focused
‘downward’ to discover plausible, finer-grained mech-
anistic generators to improve insight into the mech-
anisms operating at the level above. This process is
what Brenner and Noble describe as the ‘middle out’
approach.61
Second, a key use for multi-resolution mod-
eling is generating fast and accurate predictions,
and the focus is on inductive and deductive reason-
ing. Our interest is different: models and methods
were needed to enable mechanistic exploration and
subsequent development of improved explanations
of phenomena7,62–64 including improved phenotype
overlap (Figure 3). Improving insight requires shift-
ing the aspect of focus of new virtual experiments,
i.e., resolution tuning, in ways not easily anticipated.
Those activities require expanding the range of reason-
ing methods used to include analogical65 and abduc-
tive reasoning.7,63,64 (Figure 4).
Model Reduction Is Distinguishable from
Tuneable Resolution
Model reduction is an approach that has been used
for coarse-graining models. Although some theoret-
ical and ad-hoc methods have been used to reduce
differential equation models,66–68 there is no standard
method yet available, particularly when dealing with
multi-scale or multiple linkedmodels of different types
(e.g., hybrid models). Model reduction is guided pri-
marily by mathematical considerations (e.g., singular
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Explanatory mechanisms
Uncertainty
Reasoning
Model use
DeductiveInductive
Credible
predictions
Multi-resolution models
Low
ActualLikely
Tuneable resolution approach
Explanation
High
Abductive   Analogical
Exploration
FIGURE 4 | These four spectra inform modeling approaches,
characterize how multi-scale models can be used within the larger
biomedical context, and help distinguish our tuneable resolution
approach from multi-resolution modeling. Locations on the top two
spectra characterize the current state of knowledge about biological
systems and phenomena of interest. For immune responses to
tuberculosis (TB) and other diseases, the locations selected typically fall
within the aqua box. The pink area characterizes systems for which
trusted, ﬁne-grained explanatory mechanisms are available at the
highest level of resolution needed.
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perturbation analysis, nondimensionalization), while
resolution tuning is guided primarily by biological
considerations and questions (e.g., a need to consider
as yet unexplored molecular events, or an interest in
focusing on another aspect of the system). That said,
model reduction and a tuneable resolution approach
may in some cases lead to a similar outcome, even if
motivated by very different objectives.
EXAMPLE 1: TUNEABLE RESOLUTION
IMPLEMENTED FOR A KEY CYTOKINE
IN A MODEL OF A LUNG
GRANULOMA IN TB
The key pathologic feature of TB is the formation
of granulomas, self-organizing aggregates of immune
cells and M. tuberculosis within lungs (Figure 5(a)).
Most granulomas are capable of containing bac-
terial infection, leading to (in humans) a clinically
latent infection that may last for years. If, however,
granulomas are impaired in function, infection can
progress, granulomas enlarge, and bacteria seed
new granulomas; this sequence causes progressive
pathology, i.e., active TB disease. How the interplay
between various biological processes results in differ-
ent infection outcomes is not known, but it is clear
that granulomas play a central role. Myriad host
factors operating within and across length and time
scales influence granuloma formation and function
(a)
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FIGURE 5 | Nonhuman primate and simulated granulomas. (a)
Histopathology of a granuloma in a primate infected with
Mycobacterium tuberculosis at ∼30 weeks post-infection (courtesy of
JoAnne Flynn, University of Pittsburgh). This typical caseous granuloma
shows central necrosis (N) surrounded by macrophages (M) and an
outer cuff of lymphocytes (T cells) (L). (b) Snapshot of a simulated TB
granuloma at 200 days post-infection. Cell types: macrophages
(resting-green, activated-blue, infected-orange, and chronically
infected-red), effector lymphocytes pro-inﬂammatory interferon-𝛾
(IFN-𝛾) producing T cells-T𝛾 in pink, cytotoxic T cell-Tc in purple,
regulatory T cell-Treg in light blue, extracellular bacteria (olive green),
vascular sources-gray, necrotic spots (x). The granuloma shown in (b)
has a total bacterial load of ∼2× 105 M. tuberculosis, mostly
extracellular, proliferating and located in the necrotic core.
and thus infection outcome. Improved understanding
of mechanisms responsible for granuloma dynamics is
expected to lead to new therapeutic strategies. Because
multi-scale models can simultaneously incorporate
host–pathogen interactions occurring over molecu-
lar, cellular, and tissue scales, they are well-suited for
exploration of the immune response toM. tuberculosis
infection.
In this example, we demonstrate tuneable res-
olution by introducing a multi-scale model of gran-
uloma formation and function, fine-graining that
model to include molecular-level detail, and then
re-engineering the original model guided by insights
‘learned’ from experiments using the fine-grained
version.
GRANSIM is our ABM describing granuloma
formation and function in lungs duringM. tuberculo-
sis infection and focusing on cellular and tissue scale
dynamics69,70 (Figures 5(b) and 6(a)). Immune cells
(resting, infected, chronically infected, and activated
macrophages; regulatory, cytotoxic, and interferon-𝛾
(IFN-𝛾)-producing T cells) are represented as discrete
agents. Effector molecules [such as IFN-𝛾 and bac-
teria (extracellular, intracellular, and nonreplicating
bacteria)] are represented using continuous variables.
Each simulation follows granuloma formation and
function over several hundred days, building over
time to track thousands of individual cells (agents).
GRANSIM (and the related models described here)
were developed and achieved degrees of validation uti-
lizing extensive data from mice and primates. Simu-
lated granuloma features map to the wide spectrum of
those observed in primates, including bacterial con-
tainment, clearance (sometimes with extensive inflam-
mation), and dissemination.
GRANSIM includes only minimal informa-
tion regarding an important pro-inflammatory
cytokine, tumor necrosis factor-𝛼 (TNF). TNF is
produced by infected and activated macrophages as
a membrane-bound precursor (mTNF) that can be
cleaved and released as a soluble protein (sTNF).71,72
TNF binding to membrane receptors (TNFR1 and
TNFR2) affects the immune response to bacteria
through several mechanisms, including activation
of macrophages to more effectively kill bacteria,
induction of chemokine and cytokine expression,
and modulation of apoptosis.73–75 In humans and
nonhuman primates, TNF neutralization leads to
reactivation TB, i.e., the appearance of active disease
where it was once latent, due to a failure of granulo-
mas to control bacterial replication.76–79 Therefore,
TNF availability and activities within granulomas
are essential for restricting bacterial growth80 and
maintaining a latent infection.
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FIGURE 6 | Schematic representation of the multi-scale multi-compartment model of the immune response to Mycobacterium tuberculosis
infection. (a) An overview of selected agent-based model (ABM) rules of interaction between host cells, bacteria and lung environment as
implemented in GRANSIM69,70 which focuses on cellular and tissue scale dynamics. (b–d) Molecular-scale tumor necrosis factor (TNF) sub-model that
can be embedded at three levels of resolution [coarse (b), intermediate (c), ﬁne (d)] in GRANSIM. The molecular-scale model for TNF (c) is described
in Ref 11 and when implemented in the granuloma model is termed GRANSIMTNF (Example 1). The molecular-scale model for NF-𝜅B (d) is described
in Ref 82 and when implemented in the granuloma model is termed GRANSIMTNF-NFKB (Example 2). (e and f) The lymph node (LN) dynamics are
described as in Ref 94 at two levels of resolution [coarse (e), ﬁne (f)] (Example 3). Abbreviations: Mycobacterium tuberculosis (Mtb), macrophage
(mac), antigen (Ag), chronically infected macrophage (Mci), activated macrophage (Ma), pro-inﬂammatory IFN-𝛾 producing T cell (T𝛾 ) cytotoxic T cell
(Tc), regulatory T cell (Treg), TNF-𝛼 converting enzyme (TACE), TNF receptor types 1 and 2 (TNFR1, TNFR2), membrane and soluble forms of TNF
(mTNF, sTNF).
Availability of TNF within granulomas is
controlled not only by the rate of TNF secretion
from macrophages and TNF degradation in tissue,
but also by receptor binding and trafficking (i.e.,
receptor internalization, degradation, recycling, and
shedding) processes. Results of uncertainty and sen-
sitivity analyses demonstrated the significance of
changes in TNF availability in granuloma function
duringGRANSIM simulations, highlighting the likely
key role of TNF-related processes in controlling
actual infections. GRANSIM, however, does not
include a representation of the receptor-level pro-
cesses believed to control cellular responses and TNF
availability. To improve insight into current theories
of TNF-related mechanisms and discover new options
for targeting granulomas therapeutically, we incor-
porated TNF-related molecular-scale details and
mechanisms within GRANSIM, terming the resulting
fine-grained version GRANSIMTNF. (Figure 6(c)).
11,81
Molecular-scale dynamics of TNF/receptor bind-
ing and trafficking processes were represented as a
sub-model with a nine nonlinear ODE system solved
individually for each cell agent (i.e., macrophage or
T cell), with several thousand agents per simulation.
Simultaneously, the solution to the PDE describing
TNF diffusion at the cellular scale on the grid is com-
puted, thus linking soluble TNF concentrations at the
cellular/tissue scales to TNF binding and trafficking
events within individual cells.
232 © 2014 The Authors. WIREs Systems Biology and Medicine published by Wiley Periodicals, Inc. Volume 6, Ju ly/August 2014
WIREs Systems Biology and Medicine Tuneable resolution as a systems biology approach
TNF activates two major signaling pathways,
the caspase-mediated apoptotic and the NF-𝜅B path-
ways. In GRANSIMTNF we coarse-grain both these
pathways, linking the outputs solely to bound TNF
receptors (see Example 2 for an option that includes
detail in one of the pathways).11 TNF-induced NF-𝜅B
activation for each individual macrophage is described
as a Poisson process with a probability that is a func-
tion of the NF-𝜅B activation rate constant (kNF-𝜅B),
the concentration of TNF-bound cell surface TNFR1
complexes [C], and a threshold for those complexes
(𝜏NF-𝜅B):
PNF-𝜅B =
{
0 ;
[
C
]
< 𝜏NF-𝜅B
1 − e−kNF-𝜅B([C]−𝜏NF-𝜅B)Δt ;
[
C
]
≥ 𝜏NF-𝜅B
.
(1)
An NF-𝜅B-activated macrophage secretes
chemokines and TNF, and can be activated to kill
bacteria. The probability of TNF-induced apoptosis
for each individual cell is specified by:
Papopt =
{
0 ;
[
Ci
]
< 𝜏apopt
1 − e−kapopt([Ci]−𝜏apopt)Δt ;
[
Ci
]
≥ 𝜏apopt
,
(2)
Papopt is a function of the apoptosis rate constant
(kapopt), internalized TNF-bound TNFR1 complexes
[Ci], and a threshold for those complexes (𝜏apopt).
Equations (1) and (2) link TNF/receptor binding and
interactions to cellular scale processes.
A key GRANSIMTNF prediction is that soluble
TNF gradients form within granulomas. High con-
centrations of soluble TNF near the center of the
granuloma give way to lower peripheral concentra-
tions. Although the prediction cannot yet be val-
idated against wet-lab data, the consequences are
provocative. High central levels of TNF should trig-
ger apoptosis of infected macrophages, whereas lower
levels at the periphery should trigger survival path-
ways for T cells, which are needed to fight infection.81
Uncertainty and sensitivity analyses allowed us to
identify how TNF/TNFR binding and trafficking
dynamics may control the soluble TNF gradient.11
GRANSIMTNF can also be used to explore effects
of potential pharmacological manipulation of TNF
receptor binding and trafficking.82 For example, the
TNFR1 internalization rate constant controls the spa-
tial range of TNF action in a simulated granuloma11;
TNFR1 internalization kinetics represent a tipping
point identified by varying model resolution. Small
internalization rates lead to a greater chance of clear-
ance of the infection, but at the expense of exces-
sive inflammation due to high TNF concentrations
(Figure 7). Virtual experiments suggest that latent
Reducing TNFR1 internalization
(Example 1)
or
Enhancing NF-κB signalling
(Example 2)
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er
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FIGURE 7 | Congruent behaviors achieved from two model
resolutions. The predicted roles of TNF R1 internalization and NF-𝜅B
signaling in determining granuloma outcomes are shown. Simulations
with GRANSIMTNF (Example 1) show that reducing TNFR1
internalization enhances bacterial killing and increases the probability
of bacterial clearance. However, the increased TNF concentrations that
result give rise to excessive macrophage activation and increased tissue
inﬂammation. Simulations with GRANSIMTNF-NFKB (Example 2) show
that containment of bacteria is achieved when a balance exists between
the NF-𝜅B-mediated bacterial killing activities and the NF-𝜅B-mediated
inﬂammation. These levels of model resolution are well-suited to
exploring potential pharmacological interventions of the signaling
pathway. Snapshots of granulomas follow the same color mapping for
cells as in Figure 5. The range of behaviors simulated with the two
resolutions shows model congruency (see Figure 3).
TB represents a physiological compromise that avoids
more destructive outcomes.83
The fine-graining of our base model to include
TNF/TNF receptor binding and trafficking and
TNF-driven cell behavior was well-motivated by a
desire to understand the important roles that TNF
plays in granuloma formation and function. However,
when the focus of our virtual experiments shifts to
a new system aspect, e.g., the role of a different
cytokine or cell type, or the effect of a TNF knockout,
the model may not need extensive detail regarding
TNF. Yet we would like to retain what we learned
during the fine-graining to create GRANSIMTNF.
Thus we used a tuneable resolution approach, learn-
ing from GRANSIMTNF to re-engineer GRANSIM
(Figure 6(b)), at least with respect to TNF. Because our
analyses demonstrated the importance of the TNFR1
internalization to the fine-grained model outcomes,
we replaced the nine ODEs describing TNF receptor
binding and trafficking11 with this single ODE:
d
[
sTNF
]
dt
= k′synth −
( [
sTNF
][
sTNF
]
+ Kd1
)
kconsumption
(3)
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Equation (3) describes the change of soluble
TNF concentration within an ABM compartment that
contains a macrophage or T cell; k′
synth
is the rate of
sTNF secretion by the immune cell, and kconsumption is
the apparent rate constant for sTNF consumption (i.e.,
by internalization). The factor [sTNF][sTNF]+Kd1 represents
the sTNF-bound fraction of TNFR1s on membranes
of immune cells (assuming a pseudo steady-state).
Kd1 is TNFR1 affinity for sTNF. Because the ODEs
are being solved for each of the thousands of agents
(cells) during simulation, replacing nine ODEs with a
single ODE yields significant computational savings
(simulation times, on the order of tens of minutes,
are cut roughly in half). Note that because these are
stochastic simulations, and because it is also necessary
to run uncertainty and sensitivity analyses, thousands
of simulations are required for full analysis of the
model.
In addition, Eqs (1) and (2) are replaced with
equations that rely on the extracellular sTNF concen-
tration rather than bound TNFR1 receptors for prob-
ability computations:
PNF-𝜅B =
⎧⎪⎨⎪⎩
0 ; [sTNF][sTNF]+Kd1 < 𝜏
′
NF-𝜅B
1 − e
−k′NF-𝜅B
(
[sTNF]
[sTNF]+Kd1
−𝜏′NF-𝜅B
)
Δt
; [sTNF][sTNF]+Kd1 ≥ 𝜏
′
NF-𝜅B
, (4)
Papopt =
⎧⎪⎨⎪⎩
0 ; [sTNF][sTNF]+Kd1 < 𝜏
′
apopt
1 − e
−k′apopt
(
[sTNF]
[sTNF]+Kd1
−𝜏′apopt
)
Δt
; [sTNF][sTNF]+Kd1 ≥ 𝜏
′
apopt
, (5)
where k′NF−𝜅B, k
′
apopt, 𝜏
′
NF−𝜅B, and 𝜏
′
apopt are modi-
fied rate constants and thresholds for TNF-induced
NF-𝜅B activation and apoptosis, respectively. Because
TNF-induced responses (NF-𝜅B activation and apop-
tosis) in immune cells actually result from sTNF
binding to TNFRs on the cell membrane, TNF con-
centration thresholds 𝜏′NF−𝜅B and 𝜏
′
apopt in Eqs (4) and
(5) are defined based on [sTNF]/([sTNF]+Kd1). Initial
estimates of the values of the new model parameters
(k′
synth
, kconsumption, k
′
NF−𝜅B, k
′
apopt, 𝜏
′
NF−𝜅B, and 𝜏
′
apopt)
are based on related parameters from GRANSIMTNF.
For example, knowing the rate constant for TNFR
internalization and the average number of cell sur-
face TNFRs, we estimated a suitable range of values
for kconsumption to be on the order of kint 1[TNFR1],
where kint1 is the TNFR1 internalization rate con-
stant.
The resulting re-engineeredGRANSIM now also
predicts TNF concentration gradients within a granu-
loma and lower levels of macrophage activation and
inflammation at the periphery of granuloma, improv-
ing similarities with experimental data. Depending
on the focus of a virtual experiment, we can now
toggle between GRANSIMTNF and the re-engineered
GRANSIM (BOX 1), exercising resolution tuning and,
in the case of GRANSIM, incorporating information
regarding molecular-level TNF without the computa-
tional expense and complexity of the full model.
EXAMPLE 2: TUNEABLE RESOLUTION
IMPLEMENTED FOR NF-𝜿B SIGNALING
IN A MODEL OF A LUNG
GRANULOMA IN TB
In Example 1, we introduced GRANSIMTNF, a
hybrid multi-scale model (consisting of agent-based,
ODE, and PDE models) that simulates the immune
responses—specifically, granuloma formation and
function—during infection with M. tuberculosis
(Figure 6(a) and (c)). Although this model captures
receptor binding and trafficking processes that in
part control TNF availability, it contains limited
detail regarding the biological mechanisms that deter-
mine the relationship between TNF-bound receptors
and cellular responses (Eq. (1)). In this example,
we demonstrate tunable resolution, fine-graining
GRANSIMTNF by incorporating additional molecular
detail describing one of the intracellular signal-
ing pathways elicited by TNF binding and then
re-engineering GRANSIMTNF to increase biomimetic
fidelity.
TNF binding initiates a signaling pathway
leading to translocation of NF-𝜅B into the nucleus
and ultimately transcription of target inflammatory
genes. Activation of the NF-𝜅B pathway affects
the immune response to M. tuberculosis through
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(at least) four mechanisms in macrophages: activation
to efficiently kill bacteria, induction of chemokine
secretion, induction of cytokine (TNF) expression,
and inhibition of apoptosis.73–75,84–87 We wanted to
use virtual experiments to explore answers to ques-
tions that would require TNF signaling granularity
greater than that inGRANSIMTNF. For example, how
do the dynamics of the TNF-induced NF-𝜅B pathway
influence the long-term immune response to bacte-
ria? Could targeting the TNF-inducedNF-𝜅B pathway
affect granuloma formation and function? To under-
take those virtual experiments we developed a new
(and finer-grained) version of GRANSIMTNF, termed
GRANSIMTNF-NFKB, containing the enhanced intra-
cellular component details illustrated in Figure 6(d).82
Recent cell culture experiments, including those
in88, have identified important molecular mecha-
nisms controlling the dynamics of NF-𝜅B signaling
at the single-cell level. To explore possible influences
of this pathway in the context of host infection, we
incorporated a representation of these dynamics into
our model. Equation (1) was replaced by a set of
50 nonlinear ODEs that determine NF-𝜅B signaling
dynamics following TNF binding to cell surface TNF
receptors.82,88 Those NF-𝜅B dynamics were then
linked to the four NF-𝜅B-mediated cell responses in
macrophages listed above. NF-𝜅B-induced expression
of genes corresponding to TNF, different chemokines,
a generic inhibitor of apoptosis protein (IAP),89 and
a generic macrophage-activating molecule (ACT;
representing, for example, proteins involved in mat-
uration of phago-lysosomes essential for killing
bacteria84) as well as translation of their mRNA
transcripts were represented using ODEs. For TNF
and chemokines, ODEs also describe secretion to
extracellular spaces. For macrophage activation and
inhibition of apoptosis, because these processes are
discrete at the single-cell level, cell behavior was
described by a Poisson process with a probability
determined within each time-step in part by the
intracellular concentration of ACT and IAP, similar
to Eqs (1) and (2).82 Fine-graining NF-𝜅B dynam-
ics has two major effects on how TNF signaling
is implemented. First, the higher resolution model
(Figure 6(a) and (d)) is able to capture the dynamics
of TNF-induced responses, for example, oscilla-
tory expression of chemokines, as explored in.82
It also mathematically uncouples the four different
NF-𝜅B mediated responses, which is appropriate
as these processes are regulated by separate mecha-
nisms (transcription and translation of distinct genes
and mRNA transcripts). Virtual experiments using
GRANSIMTNF-NFKB documented that the dynamics of
TNF-induced NF-𝜅B-mediated responses are critical
to controlling bacterial load, inflammation levels, and
granuloma size82 (Figure 7).
The three model versions, GRANSIM, GRAN-
SIMTNF, and GRANSIMTNF-NFKB, correspond to the
coarse-, intermediate-, and fine-grained multi-scale
model versions shown schematically in Figure 2
(panels A1, A2a, and A3, respectively) and our
tuneable resolution implementation is described in
BOX 1. Model congruency between two of those
versions in terms of key biological outcomes is
shown schematically in Figure 7 and was obtained
using uncertainty and sensitivity analysis (Figure 3).
Although GRANSIMTNF-NFKB is the most detailed
model, not all our questions regarding TB granuloma
formation and function require this level of detail
in the NF-𝜅B pathway. Thus, our next goal was
to re-engineer and improve scientific usefulness of
GRANSIMTNF by drawing on insights gained from
GRANSIMTNF-NFKB (Figure 2, panel A2b).
Analysis of GRANSIMTNF-NFKB simulations
showed that the timing of NF-𝜅B induced macrophage
activation has a more significant effect on granuloma
function than the timing of other responses, so
we modified GRANSIMTNF to capture the timing
effects for different NF-𝜅B mediated responses in a
coarse-grained manner without solving for all reac-
tions. The timing of all NF-𝜅B mediated responses
in GRANSIMTNF is controlled by a single param-
eter kNF-𝜅B, the NF-𝜅B activation rate constant, as
described in Eq. (1). We replaced this parameter with
three independent parameters, kactivation, kchemokine,
and kTNF, controlling the timing of each individ-
ual NF-𝜅B mediated response separately (kapopt,
controlling the rate of apoptosis, already exists in
GRANSIMTNF). These parameters control the prob-
ability of each NF-𝜅B associated response within a
simulation time-step. For example, Eq. (1) is modified
to describe the probability at which a macrophage
becomes capable of secreting chemokines following
NF-𝜅B activation:
Pchemokine =
⎧⎪⎨⎪⎩
0 ;
[
C
]
< 𝜏NF-𝜅B
1 − e−kchemokine([C]−𝜏NF-𝜅B)Δt ;
[
C
]
≥ 𝜏NF-𝜅B
.
(6)
Similar to Example 1, because the ODEs are
being solved for each of the thousands of agents (cells)
in the simulation, replacing 50 ODEs determining
NF-𝜅B signaling dynamics with three ODEs yields
significant computational savings (simulation times,
on the order of several hours, are cut to tens of
minutes). Because these too are stochastic simulations,
thousands of simulations are required for uncertainty
and sensitivity analyses.
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BOX 1
EXAMPLE TUNEABLE RESOLUTION ALGORITHM
An overview of the algorithm used in simulations of the tuneable resolution multi-scale granulomamodel
with options for including TNF and NF-𝜅B sub-models (GRANSIMTNF andGRANSIMTNF-NFKB) (Examples 1 and
2). Rules and parameters for cell and bacteria processes (e.g., cell movement, cell recruitment, bacterial
growth—Figure 6(a)) are the same for different resolutions of the model.
Simulation start
Set simulation time = T
Grid initialization
Fine
Intermediate
Model
resolution
Coarse
Chemokine secretion as
described for GRANSIM
Chemokine secretion
as described GRANSIM
TNF/TNFR dynamics,
including TNF expression
as described in Example 1
Diffusion and degradation
of soluble molecules
n = n + 1
No
No
Yes
Is simulated
time ≥ T ?
Yes
Cell movements
Simulated time = N.Δt
N = N + 1
Simulation end
Cell recruitments
Extracellular Mtb growth
Cell–cell interactions
and state transitions
Fine Model
resolution
Coarse
Intermediate
TNF-induced NF-κB activation
and apoptosis as described in
Example 1, Eqs (1) and (2)
TNF-induced NF-κB activation
and apoptosis as described by
Eqs (4) and (5)
TNF-induced apoptosis as
described in Example 2
n = 1
Is n.dt = Δt?
Secretion and apparent
consumption of TNF as
described in Eq. (3)
TNF/TNFR and NF-κB
signaling dynamics,
including sercretion of
TNF and chemokines as
described in Example 2
N = n = 1
Simulation results from the re-engineered
GRANSIMTNF (Figure 8) show the importance of
kactivation and less significant effects of kchemokine
and kTNF on controlling bacteria numbers and the
level of inflammation in tissue. These results also
show model congruency between GRANSIMTNF
and GRANSIMTNF-NFKB regarding the importance
of the timing of macrophage activation in control of
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FIGURE 8 | Reﬁnement of GRANSIMTNF. Using uncertainty and sensitivity analyses and knowledge gained from GRANSIMTNF-NFKB, the
intermediate resolution model GRANSIMTNF was improved (top panels). Simulation results are shown for the timing of NF-𝜅B-mediated responses,
including macrophage activation to efﬁciently kill bacteria, TNF expression, and chemokine expression, and their effects on (a) bacteria numbers 200
days post-infection and (b) activated fraction of macrophages 50 days post-infection. Bottom panels show results from GRANSIMTNF-NFKB in which the
timing of NF-𝜅B-mediated responses is regulated by their corresponding mRNA stabilities (half-lives). Simulations are run varying the stability of
mRNA transcripts corresponding to macrophage-activating molecules, chemokines, and TNF while maintaining the average extent of the responses at
containment baseline levels.82 To maintain the average extent of each response as its corresponding mRNA stability is varied, we simultaneously vary
another parameter associated with a process downstream of mRNA translation. Parameters varied to adjust the extent of the three NF-𝜅B mediated
responses are: TNF secretion rate, chemokine secretion rate, ACT concentration threshold for macrophage activation, and macrophage activation rate
constant. Four values of mRNA half-life were tested in ﬁne-grain simulations: 12min, 30min, 1 h, and 3 h. Top panels show results from the modiﬁed
GRANSIMTNF in which the timing of NF-𝜅B-mediated responses is regulated by new parameters kactivation, kchemokine, and kTNF. Four values tested for
each of these three parameters in intermediate resolution simulations are: 1.26× 10−8, 3.97× 10−8, and 1.26× 10−7 and 3.97× 10−7 (#/cell)−1 s−1.
All other parameters are kept at their containment (baseline) levels. Simulation results are averaged over 10 repetitions.
granuloma formation and functioning. Depending on
the focus of our virtual experiments regarding TNF
and its influence on granuloma dynamics, we can now
toggle between a re-engineered GRANSIMTNF and
GRANSIMTNF-NFKB (BOX 1), exercising resolution
tuning and, in the case of GRANSIMTNF, incor-
porating information from molecular-level NF-𝜅B
simulations without the computational expense and
complexity of simulating the full model.
EXAMPLE 3: TUNEABLE RESOLUTION
IMPLEMENTED FOR A MULTI-ORGAN
MODEL OF LUNG GRANULOMA
FORMATION AND FUNCTION IN TB
In Examples 1 and 2, the multi-scale models created
added molecular-scale dynamics to a cellular/tissue
scale model. In this example, we highlight a tuneable
resolution approach when fine-graining at the same
scale as the original model. Another way to describe
this is that we add an additional compartment (organ)
to the original model.
Recruitment of immune cells to the lung to par-
ticipate in control of infection is a critical event in
granuloma formation during infection with M. tuber-
culosis. Recruited cells include T cells, macrophages,
and dendritic cells. Effector immune cells such as
CD4+ and CD8+ T cells are generated in LNs and
must travel to lungs. The process can take anywhere
from a few days to weeks for persistent pathogens
likeM. tuberculosis. Some studies show that an effec-
tive protective response to M. tuberculosis can be
impacted by this slow or delayed induction or func-
tion of effector cells.90 For example, host–bacteria
interactions can result in a delayed cell migratory
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activity or reduced antigen-presenting cell function,
at least in macrophages.91–93 In addition, timing of
initiation of granuloma formation (which is dependent
on the recruitment of these effector cells from LNs)
can affect capabilities of antigen-presenting cells (such
as macrophages and dendritic cells) to find bacteria
and migrate to draining LNs in a timely manner. Effec-
tor T cells are generated, but in most cases it is too
late to allow infection to be cleared. Instead, there is
either a ‘stand-off’ leading to latency or an active infec-
tion. Clearly, LN dynamics can have a huge impact on
the immune response toM. tuberculosis infection, and
that is the focus of Example 3.
GRANSIM is low-resolution with respect to
LN mechanisms and processes (Figure 6(a) and (e);
Examples 1 and 2).11,69,70,83 It captures effector
T cell recruitment into the lung in a simplified way, by
specifying a forcing function with a parameter repre-
senting the time of arrival of those cells to the lung.
Decisions to recruit cells and what T cell phenotypes
to recruit are based on events unfolding during
simulations. Effector T cell phenotypes are defined
based on their immunological functions: interferon-𝛾
(IFN-𝛾)-producing T cells (T𝛾), cytotoxic T cells (TC),
and regulatory T cells (Treg). T cell recruitment from
LN to lung is a stochastic event, and occurs at specific
sites (vascular sources) on the grid. To mimic the
biological delay in adaptive immunity development in
LNs, effector T cell recruitment is enabled only after
∼20 days post-infection, which reflects the typical
2–4 week post-infection ‘delay’ in mounting adap-
tive immunity. Uncertainty and sensitivity analyses
show that simulated granuloma formation is highly
dependent on the value of this delay parameter,69,70
motivating a more physiologically realistic treatment
of immune cell recruitment to the lung.
To better represent mechanisms occurring within
a LN during granuloma formation, we fine-grained
recruitment of immune cells from the LN by replacing
parameters with an entire physiological compartment
representing a LN94 (Figure 6(f), and schematically
shown in Figure 2 panels B1 to B2). Doing so allowed
us to address questions related to modulation and tim-
ing of T cell responses as a function of infection pro-
gression within the lung. We mapped a single virtual
LN to a collection of several (∼5) lung-draining LNs,
the sites of generation of effector T cells. The result-
ing multi-organ model, GRANSIM-LN, is hybrid: an
ABM for the lung compartment (Figure 6(a)) and a
nonlinear system of ODEs representing phenomena
within the LN compartment (Figure 6(f)).94 The LN
model includesmechanisms that represent antigen pre-
sentation and T cell priming and differentiation and
consists of 13 ODEs tracking APCs, naïve T cells, and
precursor, and effector CD4+ and CD8+T cells. Effec-
tor T cells can leave the LN to migrate to lungs. This
LN model was developed and calibrated using data
from M. tuberculosis-infected mice.95
Linking the LN and lung granuloma models to
form GRANSIM-LN requires specifying how cells
traffic between the compartments. To represent T
cell recruitment that is based on the level of infection
in the lung, we used the scaled sum of infected and
chronically infected macrophage populations in the
lung to represent the pool of antigen-presenting cells
that have potential to migrate to draining LNs. The
biological behavior to which this maps captures bac-
teria in lung causing more antigen-presenting cells to
ingest them and traffic to LNs. Mathematical scaling
is necessary because GRANSIM represents only a
portion of the lung, and our LN model represents
only a single draining LN. We also account for delays
that an antigen-presenting cell can encounter during
uptake, maturation, and migration processes between
physiological compartments. The scaled sum of all
infected macrophages in the lung at each time-step is
used as the initial condition for the ‘mature dendritic
cell’ (the key antigen-presenting cell in our model)
equation within the LN. After the dynamics simulate
for that time-step in the LN model, T cells generated
return to the lung via blood to participate in the lung
infection model (GRANSIM). T cell fluxes generated
by the LN model are converted into integers and
cells are placed on a queue to enter the lung when
a source location becomes available. A T cell in the
queue has a fixed lifespan. Its ‘age’ is preserved when
it enters the grid. The process is intended to mimic
the effect of effector T cells circulating through the
blood and waiting for signals to extravasate into
the tissue.96 The only recruitment parameter shared
between coarse- and fine-grained model versions,
GRANSIM and GRANSIM-LN, respectively, is a
fixed threshold for recruitment of T cells that is based
on the concentration of cytokines and chemokines at
the blood sources, where cells can enter.
Using our fine-grained model, GRANSIM-LN,
we can explore possible changes in the efficiency
and magnitude of T cell priming, differentiation,
and migration to the lung. We can also capture
the contraction phase of effector T cell fluxes due
to a reduction of antigen-presenting cells migrating
to LNs.
GRANSIM-LN experiments demonstrated that
detectable levels of effector T cells at the site of
infection occur only above a threshold number of
bacteria in the lung. On the basis of that observa-
tion, we re-engineered the original GRANSIM by
introducing a new threshold parameter. When total
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bacteria counts in the lung ABM are greater than this
threshold, T cell recruitment is enabled. To create
this re-engineered GRANSIM, we focused on one
of the most informative proxies for infection in the
lung, the total bacteria count. We used measures from
GRANSIM-LN to create a proxy function of total
bacteria versus T cell fluxes from LN to lung. In order
to simulate a large spectrum of granuloma outcomes
ranging from clearance to dissemination, we varied
12GRANSIM parameters (while fixing the LN model
parameters) and generated 900 different temporal
bacteria profiles. We plotted daily bacteria counts
versus T cell flux (Figure 9; only T𝛾 fluxes are dis-
played). Figure 9(a) shows a clear separation of fluxes
as infection progresses. We then fit time-adjusted
functions to the data (Figure 9(b)) and generated an
improved GRANSIM (Figure 9(c)).
Thus we have two model versions, in terms
of incorporation of LN dynamics, the re-engineered
GRANSIM and the fine-grained GRANSIM-LN; we
can choose the appropriate version for the biological
aspect of interest. (When needed, we also have a
LN ABM that tracks individual cell movements and
generation of effector T cells within a LN, but its
details are beyond the scope of this example.49,97–99
Our tuneable resolution approach gives us the
ability to toggle easily between different model ver-
sions to continually improve explanatory mechanis-
tic insights and expand the scope of those insights.
That process is illustrated by the data in Figure 10.
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FIGURE 9 | Comparisons of T𝛾 cell ﬂuxes across different model resolutions. T cells that make the cytokine IFN-𝛾 (T𝛾) are shown on the y-axis.
The x-axis represents total bacteria count. Each plot displays a total of 900× 200 points. Each point is the combination of total bacteria count and T𝛾
cell ﬂuxes at a certain day during a simulated 200-day infection. Different colors correspond to different time intervals. (a) Results using the
ﬁne-grained version of T cell recruitment (GRANSIM-LN). (b) The data from (a) with examples of linear and quadratic functions superimposed to ﬁt
the data. (c) Results using the improved coarse-grained model in which the ﬁne-grained ﬂuxes in (a) are approximated using the linear and quadratic
functions illustrated in (b). For days 0–60, we use linear approximations. For days 60–200 we use quadratic functions. We ﬁt simulated T𝛾 and TC
ﬂuxes separately. In order to cross-validate with ﬁne-grained LN outcome distributions, we truncated the approximations at a certain level of total
bacteria, below which the ﬂux becomes 0. For example after day 30, if bacteria<35, ﬂuxes are set to 0.
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FIGURE 10 | Outcome distributions across different model resolutions describing T cell recruitment. Total bacteria count at day 200 is used as
proxy for TB outcome (x-axis). Each plot displays the outcome from 900 different parameter combinations resulting from the virtual experiments
described in the text. Each point is the combination of total bacterial count and T𝛾 cell ﬂuxes at 200 days post infection. (a) GRANSIM.
(b) GRANSIM-LN. (c) re-engineered GRANSIM.
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Results from the re-engineeredGRANSIM differ from
the other resolutions: using the same set of parameter
values shared across versions, it returns more total
bacteria in the range of 0–1000 (Figure 10(a)). This
demonstrates that the original GRANSIM formula-
tion of T cell recruitment skews the results towards
a more likely resolution of the infection by superim-
posing a fixed time for enabling T cell recruitment,
as well as continuous unlimited availability of effec-
tor T cells, regardless of the level of infection in the
lung. This highlights the use of tuneable resolution
to identify a model flaw. Although the re-engineered
GRANSIM (Figure 10(c)) gives more accurate predic-
tions, computational efficiency is not affected (we are
solving a single ODE that only occurs in one step of the
model). In other work with a multi-organmodel, how-
ever, tuneable resolution allowed a 17-fold increase in
computational efficiency.49
DISCUSSION
Systems biologists are leveraging multi-scale model-
ing methods to study important biomedical problems
in new ways. These models are exciting and we need
new approaches to help with analyses, expand sci-
entific and medical relevance, and promote sharing
capabilities. We argue that developing and building
models with tuneable resolution is a step in that direc-
tion. Tuneable resolution begins with a multi-scale
model in place and strives to make model mechanisms
more explanatory and thus more biomedically rele-
vant, while simultaneously making them more useable
and understandable. Our approach is applicable not
only for systems that are multi-scale in space (includ-
ing multi-organ) and time, but also for models that
are multi-dimensional. In Ref 97, e.g., we develop an
ABM of the LN that can be used in 2 or 3 dimensions.
Different features of the tuneable resolution
approach that we describe here have been employed
recently in other contexts. As examples, Gary An uses
variable resolution components within a multi-scale
model to explore and study the pathogenesis of mul-
tiple organ failure.100 An additional model use is
enabling dynamic knowledge representation within
the multi-scale model’s modular architecture. Lam and
Hunt38 used sequential changes in micro-mechanism
resolution to improve explanatory insight into the
paradoxical roles of P-glycoprotein, Cyp3A4 enzymes,
and sub-cellular microenvironments in determining
temporal patterns of transport and metabolism of
saquinavir (an antiretroviral drug) in Caco-2 cell
cultures. Focusing on explanatory cell-level mecha-
nisms of epithelial cell cystogenesis in cultures, Kim
and Hunt101 used resolution tuning to evolve fully
rule-based cell agents into composite counterparts
that achieved quantitative cross-model validation
targets under normal and dysregulated conditions.
Ruiz-Herrero et al. developed a coarse-grained model
of receptor–ligand binding, allowing computation-
ally efficient consideration of some spatial aspects
of interactions.102 Tang et al.14,103,104 altered the
resolution of different multi-scale model components
in order to enable dynamic simulation results to
achieve quantitative validation targets drawn from
a variety of different experimental conditions. It is
useful to view all of these from within the framework
of tuneable resolution provided here.
A current weakness of the tuneable resolution
approach is that it is relatively new and in use in only
a few laboratories. It is not yet clear how established
good modeling and simulation practices will need
to be expanded to cover the new methods. Figure 2
serves to highlight an issue for which additional
best practice guidelines may be needed. During each
tuning exercise, there are frequent opportunities to
introduce bias, artifacts, and/or seed an inscription
error7,105 (http://furm.org/glossary.html), which—if
unnoticed—will jeopardize the scientific usefulness of
subsequent model refinements. The risks are some-
what amplified because we are working in the aqua
area of Figure 4, striving to move rightward. Conse-
quently, the models are perpetual works in progress.
The best strategy is to reinforce adherence to good
modeling and simulation practices, and that includes
keeping records of tuning protocols, consequences,
inferences, decisions, and evidence of feature falsi-
fication. The ideal course for model improvement
(Figure 3) anticipates incremental tuning to expand
both coarse- and fine-grain model overlap. However,
tuning to improve overlap in one ‘direction’ may come
at the cost of reduced consistency in areas previously
covered. A mitigating strategy is to expand the variety
of qualitative (and, later, quantitative) validation
targets and/or increase the variety of biomimetic
constraints, and confirm through in silico experimen-
tation that those targets are still achieved. Doing so,
however, places an additional demand on modeler
efforts. Because tuning is currently a hands-on activity,
considerable time and effort may be required to suc-
cessfully complete several tuning cycles, and that can
be considered a shortcoming. A mitigating strategy is
to increase modularity at both mechanism description
and software levels so that refactoring decreases as
explanatory power increases. The technical challenges
faced when switching between coarse and fine-grain
components are common to all multi-scale mod-
eling efforts and are well understood.7–9,30–38,59,60
Consequently, efficient resolution tuning should
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be a priority requirement at the beginning of a
project because it can influence selection of modeling
methods.
We envision that the most efficient and produc-
tive path to more effective and eventually curative
therapeutic intervention strategies for TB and other
diseases will involve many cycles through the right
side of Figure 1 coupled with the occasional but essen-
tial cycle through the left side. The approach can be
extended to and beyond clinical trials. We anticipate
new knowledge falsifying some model and/or assump-
tion details, requiring feature revision and inclusion
of new features. We do not anticipate those future vir-
tual experiments, even those requiring virtual patients,
to utilize a single, grand, unified multi-scale model,
however. Because each virtual experiment will be
motivated by a specific question or hypothesis, it
will, like wet-lab counterparts, focus on just one (or
at most a few) aspect of the disease and its con-
text. As was the case for Examples 1–3, we expect
the model used to be somewhat individualized (and
somewhat optimized, from an execution perspective)
for the particular virtual experiment and its uses:
easily (ideally automatically) assembled from a fam-
ily of exchangeable model components, each having
achieved aspect-specific validation targets. Because TB
phenomena are multi-scale within and across many
aspects of the disease, we anticipate that many of those
virtual experiments will require a resolution change
one or more times during execution. Thus, we argue
that having, expanding, and improving that capability
is essential to achieving important public health out-
comes from computational models.
A multi-scale model that has resolution-tuning
capabilities and has earned a degree of credibility pro-
vides improved, plausible explanations of how events
may coalesce into phenomenawithin and between bio-
logical scales. Such improved insight—improvement
in the theory of TB, in our examples—is often infeasi-
ble to achieve through wet-lab experimentation alone.
The most frequently touted benefit of multi-scale
modeling is improved predictions. We have demon-
strated how improved scientific value can be derived
from exploring and refining plausible, explanatory
multi-scale mechanisms using a tuneable resolution
approach.
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